Create a lasting legacy to fund future research and support programs by donating to The Teal Trust.
Including OCRA in your estate plan is an easy way to commit to funding crucial research for ovarian and related gynecologic cancers now and in the future.
Your lawyer or financial advisor can assist with either creating or adjusting your estate plans.
We recommend that your bequest be designated for unrestricted purposes or be directed to general research because we cannot predict future medical advances or the future of our patient support programs.
FreeWill, a secure online resource that we have partnered with, guides you through the process of making or updating a legally valid will and including a gift to OCRA. The entire process takes less than 20 minutes and is 100% free. This is an easy way to help patients and support survivors well into the future.
FreeWill can also help you easily plan beneficiaries for your non-probate assets (such as an IRA, 401(k), life-insurance policy, or any other assets not included in your will) in one place. You can even designate OCRA as a beneficiary of these kinds of assets if you choose.
Please fill out this form to let us know so we can say thank you and update our records!
Email donations@ocrahope.org or call 212-268-1002 to notify us of your plans or for further information.
This article was updated in October 2025 to reflect NCCN’s release of the 2025 Guidelines for Uterine Cancer Patients. OCRA is a proud sponsor of the 2025 Patient Guidelines for Cervical, Ovarian, and Uterine Cancer. We believe ensuring access to clear, understandable information is critical. NCCN provides wonderful guides for anyone newly diagnosed to help … Continued
In a recent article for the Fort Worth Star-Telegram, Jeff Guttenfelder spoke with journalist Ciara McCarthy about losing his late wife, Ni, to ovarian cancer, and how he is channeling his grief into action through participation in OCRA’s Survivors Teaching Students program. Read the article “Fort Worth man’s wife died of ovarian cancer” in the … Continued
KVIA-TV ABC-7 News El Paso recently spotlighted the groundbreaking work of OCRA-funded researcher Daniel Heller, PhD of Memorial Sloan Kettering Cancer Center, whose research lab is working to develop a liquid biopsy that uses nanotechnology and artificial intelligence (AI) to detect ovarian cancer earlier. We’re developing a liquid biopsy that uses nano sensors and AI … Continued
Get email updates about research news, action alerts, and ways to join the fight.
